CareDx Announces Second Quarter 2025 Financial Results
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Business Wire
Grew Testing Services Volume to Approximately 49,500, Increase of 13% Year-Over-YearAlloSure Kidney Testing Volumes Grew Nearly 20% Year-Over-YearNarrows Full Year 2025 Revenue Guidance to $367 Million to $373 Million BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company - a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the second quarter ended June 30, 2025.Second Quarter 2025 Financial HighlightsReported revenue of $86.7 million including a $3.8 million write-off of aged receivables associated with tests performed in prior periodsAdjusted revenue of $90.5 million, an increase of 14% year-over-yearGAAP testing services revenue of $62.0 million, a decrease of 13% year-over-yearAdjusted testing services revenue of $65.9 million, an increase of 14% year-over-yearTes
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]Seeking Alpha
- CareDx (NASDAQ:CDNA) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CDNA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> froMarketBeat
- CareDx Provides Notice of Proposed Derivative Settlement [Yahoo! Finance]Yahoo! Finance
- CareDx Provides Notice of Proposed Derivative SettlementBusiness Wire
CDNA
Earnings
- 11/4/25 - Beat
CDNA
Sec Filings
- 12/18/25 - Form 8-K
- 12/15/25 - Form 8-K
- 12/5/25 - Form 4
- CDNA's page on the SEC website